ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $963,592 | -27.9% | 162,769 | -9.6% | 0.00% | – |
| Q2 2023 | $1,336,676 | -21.6% | 180,145 | -0.2% | 0.00% | -100.0% |
| Q1 2023 | $1,705,706 | +97592.2% | 180,498 | +10.1% | 0.00% | 0.0% |
| Q4 2022 | $1,746 | -99.8% | 163,920 | +39.5% | 0.00% | – |
| Q3 2022 | $867,000 | +561.8% | 117,516 | +330.4% | 0.00% | – |
| Q2 2022 | $131,000 | -6.4% | 27,304 | 0.0% | 0.00% | – |
| Q1 2022 | $140,000 | -10.8% | 27,304 | +4.6% | 0.00% | – |
| Q4 2021 | $157,000 | +60.2% | 26,109 | +135.7% | 0.00% | – |
| Q3 2021 | $98,000 | – | 11,079 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 2,000,000 | $15,240,000 | 3.97% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 45,910 | $350,000 | 0.19% |
| Interchange Capital Partners, LLC | 24,420 | $186,000 | 0.10% |
| GOODWIN DANIEL L | 20,000 | $152,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 39,006 | $297,000 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,399 | $643,000 | 0.01% |
| BLAIR WILLIAM & CO/IL | 34,766 | $265,000 | 0.00% |
| Hartford Financial Management Inc. | 598 | $5,000 | 0.00% |
| HAP Trading, LLC | 25,100 | $27,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,374 | $11,000 | 0.00% |